$19.93
-0.05-0.25%
At close: -
$19.93
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Celldex Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CLDX | Benzinga
Celldex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$-0.790
Quarterly Revenue Estimate
$433.33K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$7.02M
Analyze the earnings history of Celldex Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics | -$0.56 | -$0.79 | — | — | $156.00K | $433.33K | — | — | 05/05/2025 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.83 | -$0.73 | -$0.71 | 2.74% | $4.13M | $1.31M | $1.18M | -10.31% | 02/27/2025 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.81 | -$0.68 | -$0.64 | 5.88% | $1.52M | $920.00K | $3.19M | 246.85% | 11/06/2024 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.65 | -$0.60 | -$0.54 | 10.00% | $268.00K | $820.43K | $2.50M | 204.47% | 08/08/2024 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.62 | -$0.69 | -$0.56 | 18.84% | $967.00K | $920.00K | $156.00K | -83.04% | 05/06/2024 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.56 | -$0.74 | -$0.83 | -12.16% | $1.61M | $840.00K | $4.13M | 391.90% | 02/26/2024 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.57 | -$0.68 | -$0.81 | -19.12% | $407.00K | $580.00K | $1.52M | 161.55% | 11/02/2023 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.77 | -$0.67 | -$0.65 | 2.99% | $163.00K | $530.00K | $268.00K | -49.43% | 08/08/2023 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.49 | -$0.63 | -$0.62 | 1.59% | $174.00K | $410.00K | $967.00K | 135.85% | 05/04/2023 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.43 | -$0.59 | -$0.56 | 5.08% | $333.00K | $260.00K | $1.61M | 520.38% | 02/28/2023 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.37 | -$0.58 | -$0.57 | 1.72% | $153.00K | — | $407.00K | — | 11/09/2022 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.34 | -$0.51 | -$0.77 | -50.98% | $3.48M | $400.00K | $163.00K | -59.25% | 08/08/2022 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.42 | -$0.45 | -$0.49 | -8.89% | $685.00K | $560.00K | $174.00K | -68.93% | 05/05/2022 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.55 | -$0.42 | -$0.43 | -2.38% | $3.79M | — | $333.00K | — | 02/28/2022 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.36 | -$0.37 | -$0.37 | 0.00% | $668.00K | $1.12M | $153.00K | -86.34% | 11/09/2021 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.50 | — | -$0.34 | — | $236.00K | $685.00K | $3.48M | 408.03% | 08/05/2021 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.73 | -$0.38 | -$0.42 | -10.53% | $2.73M | $685.00K | $685.00K | 0.00% | 05/06/2021 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.64 | — | -$0.55 | — | $887.00K | — | $3.79M | — | 03/29/2021 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.75 | — | -$0.36 | — | $546.00K | — | $668.00K | — | 11/05/2020 | Get Alert |
| CLDX | Celldex Therapeutics | -$0.84 | -$0.58 | -$0.50 | 13.79% | $715.00K | $800.00K | $236.00K | -70.50% | 08/06/2020 | Get Alert |
| CLDX | Celldex Therapeutics | -$1.40 | — | -$0.73 | — | $1.43M | — | $2.73M | — | 05/06/2020 | Get Alert |
Celldex Therapeutics (CLDX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.71 | $-0.73 | 2.74 % |
| Q3 | 2024-11-06 | $-0.64 | $-0.68 | 5.88 % |
| Q2 | 2024-08-08 | $-0.54 | $-0.60 | 10.0 % |
| Q1 | 2024-05-06 | $-0.56 | $-0.69 | 18.8 % |
Celldex Therapeutics (CLDX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $1.18M | $1.31M | -10.3 % |
| Q3 | 2024-11-06 | $3.19M | $920.00K | 246.9 % |
| Q2 | 2024-08-08 | $2.50M | $820.43K | 204.5 % |
| Q1 | 2024-05-06 | $156.00K | $920.00K | -83.0 % |
FAQ
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics (CLDX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Celldex Therapeutics (NASDAQ:CLDX)?
The Actual EPS was $-0.71, which beat the estimate of $-0.73.
What were Celldex Therapeutics’s (NASDAQ:CLDX) revenues?
The Actual Revenue was $1.2M, which missed the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.